Home > Drug Search >
  • company_query: Affimed
  •   > 
Drug Filter
Category:
chemistry (5) biology (22)
Status:
Approved (4) BLA Filing (1) Phase Ⅲ (2) Phase Ⅱ (11) Phase Ⅰ (9)
Clinical Stage:
Pending (3) Active (19) Discontinued (1)
Bio-Type:
Blood extraction (1) Microbial extract (1) Recombinant enzyme (2) Recombinant coagulation factor (3) Whole antibody (5)
Indication:
Non-alcoholic steatohepatitis (1) Acute myeloid Leukemia (AML) (1) Basal cell carcinoma (BCC) (1) Breast cancer (1) Cancer chemotherapy (1) Rectal cancer (1) Gastric cancer (1) Gaucher's disease (GD) (1) Alcoholic hepatitis (1) Glabellar line (1) Myocardial infarction (MI) (1) Non-Hodgkin’s lymphoma (NHL) (2) Pancreatic cancer (2) Psoriasis (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (3) Solid tumours (3) Systemic lupus erythematosus (2) Nasopharyngeal cancer (1) Hodgkin lymphoma (1) Colorectal cancer (1) Primary humoral immunodeficiency (1) Age-related macular degeneration (AMD) (2) Autistic disorder (1) Hemophilia A (2) Hemophilia B (1) Prediabetes (1) Adrenocortical carcinoma (1) Cardiac reperfusion injury (1) hematological malignancies (1) Sciatica (1) Inflammation (1) Immune thrombocytopenic purpura (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top